Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Nuclear Medicine Equipment Market Size, Value And Growth Trajectory Through 2030
The nuclear medicine equipment market has demonstrated robust growth in its size over recent years. It is projected to expand from $2.81 billion in 2025 to $2.97 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.7%. Historically, this expansion can be ascribed to factors like the increasing aging population, a rise in cancer prevalence, the greater embrace of diagnostic imaging, improvements in hospital infrastructure, and governmental financial support for nuclear medicine.
The nuclear medicine equipment market is projected to experience robust expansion over the next few years. It is anticipated to reach $3.67 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 5.4%. This growth during the forecast period is attributable to factors such as increased theranostics adoption, escalating demand for precision medicine, technological advancements in hybrid imaging, the rising burden of cardiovascular diseases, and the expansion of imaging centers within emerging markets. Major trends for the forecast period encompass advanced hybrid imaging systems, broadened theranostics applications, a greater embrace of personalized nuclear diagnostics, an enhanced focus on radiation dose optimization, and an increasing demand for outpatient nuclear imaging services.
Get A Free Sample Report With In-Depth Market Insights:
Nuclear Medicine Equipment Market Growth Backed By Core Demand Fundamentals
The future expansion of the nuclear medicine equipment market is anticipated to be driven by the rising incidence of cardiac ailments. These conditions, also referred to as heart or cardiovascular diseases, encompass a wide array of disorders that impact the heart and blood vessels, potentially affecting heart function, structure, or the flow of blood. The widespread occurrence of cardiac ailments stems from factors such as an aging demographic, lifestyle choices including poor diet and insufficient exercise, exposure to environmental factors, and enhancements in diagnostic tools leading to improved detection rates. Nuclear medicine equipment plays a crucial role in managing cardiac ailments by delivering precise imaging and diagnostic insights, which are essential for early discovery, accurate disease staging, and efficient monitoring. For instance, in January 2024, data from the British Heart Foundation, a UK-based cardiovascular research charity, indicated that approximately 7.6 million people in the UK suffer from heart and circulatory diseases, comprising around 4 million males and 3.6 million females. These conditions account for about 27% of all deaths in the UK, totaling over 170,000 deaths annually, which averages roughly 480 deaths per day, equivalent to one death every three minutes. Consequently, the increasing prevalence of cardiac ailments is a key factor propelling the growth of the nuclear medicine equipment market.
Nuclear Medicine Equipment Market Segment Performance And Emerging Opportunities
The nuclear medicine equipment market covered in this report is segmented –
1) By Product: Single Photon Emission Computed Tomography, Hybrid Positron Emission Tomography, Planar Scintigraphy
2) By Application: Oncology, Cardiology, Neurology, Other Applications
3) By End User: Hospitals, Imaging Centers, Academic And Research Institutes, Other End Users
Subsegments:
1) By Single Photon Emission Computed Tomography: Standalone SPECT Systems, Hybrid SPECT Or CT Systems
2) By Hybrid Positron Emission Tomography: PET Or CT Systems, PET Or MRI Systems
3) By Planar Scintigraphy: Cardiac Imaging Systems, Bone Scintigraphy Systems, Thyroid Imaging Systems
Nuclear Medicine Equipment Market Growth Trends Reshaping The Competitive Landscape
Leading companies in the nuclear medicine equipment market are concentrating on developing sophisticated products, such as PET/CT scanners, to deliver exceptionally detailed, functional imagery of the body’s metabolic activities. A PET/CT scanner is an advanced diagnostic imaging tool utilized in nuclear medicine, which integrates two distinct technologies: positron emission tomography (PET) and computed tomography (CT). This combined-modality scanner offers both functional and anatomical imaging within one session, thereby enabling physicians to identify and diagnose a range of conditions with greater precision. For instance, an example of this trend is the launch of the Biograph Trinion PET/CT scanner by Siemens Healthineers, a Germany-based healthcare firm, in June 2024. This PET scanner features an innovative, scalable axial field-of-view design, facilitating technological enhancements on-site without requiring expensive room modifications or interrupting operational flow. It incorporates a lutetium oxyorthosilicate (LSO) crystal detector, delivering high spatial resolution and an exceptionally fast time-of-flight performance of 239 picoseconds, which improves the detection of small lesions and provides sufficient sensitivity up to 128 cps/kBq. Consequently, this allows for quicker scans while simultaneously lowering patient radiation exposure. Furthermore, the Biograph Trinion is equipped with a novel air-cooled digital detector, streamlining installation in contrast to conventional water-cooled setups.
Nuclear Medicine Equipment Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the nuclear medicine equipment market are Fujifilm Holdings Corporation, Koninklijke Philips N.V., General Electric Company, Shimadzu Corporation, Mallinckrodt Pharmaceuticals, Curium Pharma, Cardinal Health Inc., Canon Medical Systems Corporation, Digirad Corporation, TTG Imaging Solutions, Biodex Medical Systems Inc., Spectrum Dynamics Medical, Mediso Ltd., Cyclopharm Limited, Siemens Healthineers AG, Capintec Inc., Toshiba Medical Systems Corporation, Elysia-Raytest, DDD-Diagnostic A/S, MILabs B.V.
View The Full Nuclear Medicine Equipment Market Report:
Nuclear Medicine Equipment Market Geographic Spread And Regional Opportunities
North America was the largest region in the nuclear medicine equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
